BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38743721)

  • 1. Treatment success rate and associated factors among drug susceptible tuberculosis individuals in St. Kizito Hospital, Matany, Napak district, Karamoja region. A retrospective study.
    Opito R; Kwenya K; Ssentongo SM; Kizito M; Alwedo S; Bakashaba B; Miya Y; Bukenya L; Okwir E; Onega LA; Kazibwe A; Othieno E; Kirya F; Olupot PO
    PLoS One; 2024; 19(5):e0300916. PubMed ID: 38743721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of tuberculosis in children in Kampala district, Uganda, 2009-2010; a retrospective cross-sectional study.
    Wobudeya E; Lukoye D; Lubega IR; Mugabe F; Sekadde M; Musoke P
    BMC Public Health; 2015 Sep; 15():967. PubMed ID: 26407719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of drug resistant tuberculosis in a predominantly nomadic population in Uganda: a mixed methods study.
    Simbwa BN; Katamba A; Katana EB; Laker EAO; Nabatanzi S; Sendaula E; Opio D; Ictho J; Lochoro P; Karamagi CA; Kalyango JN; Worodria W
    BMC Infect Dis; 2021 Sep; 21(1):950. PubMed ID: 34521382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of empiric treatment for pediatric tuberculosis, Kampala, Uganda, 2010-2015.
    Wobudeya E; Jaganath D; Sekadde MP; Nsangi B; Haq H; Cattamanchi A
    BMC Public Health; 2019 Apr; 19(1):446. PubMed ID: 31035984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of tuberculosis treatment success among HIV-TB co-infected patients attending major tuberculosis treatment sites in Abeokuta, Ogun State, Nigeria.
    Akanbi K; Ajayi I; Fayemiwo S; Gidado S; Oladimeji A; Nsubuga P
    Pan Afr Med J; 2019; 32(Suppl 1):7. PubMed ID: 30984328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
    Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
    AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric tuberculosis outcomes and factors associated with unfavorable treatment outcomes in Botswana, 2008-2019: a retrospective analysis.
    Siamisang K; Rankgoane-Pono G; Madisa TM; Mudiayi TK; Tlhakanelo JT; Mubiri P; Kadimo K; Banda FM; Setlhare V
    BMC Public Health; 2022 Nov; 22(1):2020. PubMed ID: 36333805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of socio-economic factors on Tuberculosis treatment outcomes in north-eastern Uganda: a mixed methods study.
    Nidoi J; Muttamba W; Walusimbi S; Imoko JF; Lochoro P; Ictho J; Mugenyi L; Sekibira R; Turyahabwe S; Byaruhanga R; Putoto G; Villa S; Raviglione MC; Kirenga B
    BMC Public Health; 2021 Nov; 21(1):2167. PubMed ID: 34836521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with unfavourable tuberculosis treatment outcomes in Lusaka, Zambia, 2015: a secondary analysis of routine surveillance data.
    Nanzaluka FH; Chibuye S; Kasapo CC; Langa N; Nyimbili S; Moonga G; Kapata N; Kumar R; Chongwe G
    Pan Afr Med J; 2019; 32():159. PubMed ID: 31308862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of tuberculosis and its response to anti-TB drugs among tuberculosis patients treated under the TB control programme at Felege-Hiwot Referral Hospital, Ethiopia.
    Zenebe Y; Adem Y; Mekonnen D; Derbie A; Bereded F; Bantie M; Tulu B; Hailu D; Biadglegne F
    BMC Public Health; 2016 Aug; 16():688. PubMed ID: 27485507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcome of tuberculosis patients under directly observed treatment short course and its determinants in Shangla, Khyber-Pakhtunkhwa, Pakistan: A retrospective study.
    Ahmad T; ; Khan M; Khan MM; Ejeta E; Karami M; Ohia C
    Int J Mycobacteriol; 2017; 6(4):360-364. PubMed ID: 29171450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study.
    Kizito E; Musaazi J; Mutesasira K; Twinomugisha F; Namwanje H; Kiyemba T; Freitas Lopez DB; Nicholas NS; Nkolo A; Birabwa E; Dejene S; Zawedde-Muyanja S
    BMC Infect Dis; 2021 Mar; 21(1):292. PubMed ID: 33752637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at public hospitals in Southern Ethiopia.
    Dawit Z; Abebe S; Dessu S; Mesele M; Sahile S; Ajema D
    PLoS One; 2021; 16(6):e0253449. PubMed ID: 34191846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with unsuccessful treatment outcome in tuberculosis patients among refugees and their surrounding communities in Gambella Regional State, Ethiopia.
    Ejeta E; Beyene G; Balay G; Bonsa Z; Abebe G
    PLoS One; 2018; 13(10):e0205468. PubMed ID: 30335777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTS programme in Addis Ababa, Ethiopia.
    Getahun B; Ameni G; Biadgilign S; Medhin G
    BMC Infect Dis; 2011 May; 11():127. PubMed ID: 21575187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
    PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and treatment outcomes of recurrent tuberculosis in Tanzania from 2018 to 2021 using the National TB dataset.
    Njiro BJ; Kisonga R; Joachim C; Sililo GA; Nkiligi E; Ibisomi L; Chirwa T; Francis JM
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011968. PubMed ID: 38359088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Outcome of Tuberculosis Patients under Directly Observed Treatment Short Course and Factors Affecting Outcome in Southern Ethiopia: A Five-Year Retrospective Study.
    Gebrezgabiher G; Romha G; Ejeta E; Asebe G; Zemene E; Ameni G
    PLoS One; 2016; 11(2):e0150560. PubMed ID: 26918458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses.
    Pepper DJ; Rebe K; Morroni C; Wilkinson RJ; Meintjes G
    PLoS One; 2009; 4(2):e4520. PubMed ID: 19229341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.